Sadik Kassim is a scientist and executive with extensive experience in the biotechnology industry with a specific focus on cell and gene therapy bioprocessing and translational research. Tim received his A.B. Emilys primary responsibility at RA Capital isdesigning and overseeing the brand management for RA Capital's internal and external communications as well assisting with the brand identity forportfolio companiesfounded through RA Capital's incubator, RA Ventures. He is also an active member of the Big Brothers of Massachusetts Bay program. Gerald is Vice President of Scientific Operations at RA Ventures (RAVen). Prior to RA, Christy was a Senior Scientist in Oncology Target Discovery at Pfizer. Mark brings to RAVen more than twenty-five years of leadership experience in the life sciences industryspanning operations, corporate development, legal affairs, and intellectual property. Prior to Tamarack, Brian held roles as Associate Portfolio Manager and Research Analyst, Healthcare, at Sonar Capital Management. in Neuroscience from University of Pennsylvania and a PhD in Neuroscience from University of Oxford. Jacqueline is an Associate, Strategic Finance at RA Capital Management. Prior to management consulting, Mr. Grau was Director of Marketing & Business Development at a clinical information technology startup. Prior to RA, Megan worked as a Gastroenterology Fellow at University of Pittsburgh Medical Center and a Resident Physician, Internal Medicine, at Beth Israel Deaconess Medical Center. Kate McKenna is a Compliance Associate at RA Capital Management. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Prior to joining RA Capital, Emilie was a Vice President of Investor Relations at THL Credit. Raj is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Brett holds a BS from Washington University, St. Louis and a JD from Duquesne University School of Law and is admitted to practice law in PA. Brett previously served as a Clerk for the Washington County Court of Common Pleas in PA. Emilie Schleer is the Senior Investor Relations Manager with the Operations Team at RA Capital Management. He completed an internship in Internal Medicine and residency in Psychiatry at the University of Utah Health Sciences Center. Mario received postdoctoral training at the NIH and Mount Sinai School of Medicine in innate immunity and bioinformatics, earned a PhD in microbiology at University of Chile and a MS in Nuclear Physics. He also provided additional system administration and training for the desktop engineering team. Max has a BS in Biology from the State University of New York at Fredonia and a PhD in Cellular and Molecular Biology from the University of Michigan. Founders GSAS Harvard Biotech Club Americas +1 212 318 2000. Prior to this role, Erich mapped a number of competitive landscapes including lung cancer, obesity, and chronic kidney disease. He was a faculty member at the University of Rochester School of Medicine prior to joining Merck Research Laboratories in 2004. We owe a debt to the people who have mentored us, and we in turn have a responsibility to turn our hard won lessons into a solid foundation for our industry's emerging innovators and leaders.. I would love to talk to the 1 out of 7 VCs who thinks non-orphan small molecules for older patients are just as investable post Cristina Ghenoiu is a Principal on the Venture Team at RA Capital Management. Rez holds a BSc in biochemistry and PhD in cell biology from Newcastle University, UK. Emory Werner is an Associate with the TechAtlas division of RA Capital Management. Katherines primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Garrett has over 20 years of experience in cell and gene therapy, including over 12 years in roles of increasing responsibility in biotech companies, including with Bluebird Bio, Audentes Therapeutics, and Ambys Medicines, and he was most recently the VP of Gene Therapy at Voyager Therapeutics. She worked previously in desktop publishing and as a freelance designer. Joshs primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Ed began his career working with neurologically active compounds at Allergan, CoCensys, and Serono. Mariagrace previously worked as an Executive Assistant at MPM Capital. Brendan is a Tax Director at RA Capital Management. David holds a PhD from Harvard University in Biophysics and a BS in Molecular Biology from Texas A&M University. Sri Mahendra is a Senior Software Engineer at RA Capital Management. Adam received his JD from the University of Virginia School of Law, and his BA from Whittier College. In this role he works closely with RAs Venture Team to evaluate various drug discovery platforms and initiate novel therapeutics programs. Alexs primary responsibilities at RA Capital are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context, as well as advising RA's portfolio companies on many aspects of program and pipeline strategy. Prior to that, he held roles as Executive Vice President, Global Head Specialty Medicine and Vice President, Ophthalmology/Global Launch Team Head, EYLEA. MarketScreener: Created by Investors for Investors! Habib brings to RAVen nearly three decades of experience as a strategic leader in Big Pharma and emerging Biotech. Sonias primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Michael earned a DVM at the University of Pretoria and a PhD in Immunology at the University of Pennsylvania. from Harvard College and an M.B.A. from Harvard Business School. Shannon's primary responsibilities are to manage the front desk and office facilities. Timothy is a veteran biotech leader with deep experience in growing companies and bringing innovative therapies to market. Alex Martinez-Forte is an Analyst, Strategic Finance at RA Capital Management. His primary responsibilities are to assist with accounting, financial reporting and investment valuation. Prior to this role, Alyssa mapped a number of competitive landscapes of drugs and medical devices for disease indications and capabilities. She received a BA from Princeton University and an MBA from Harvard Business School. Tylers primary responsibility at RA Capital isdesigning and maintaining the RA Capital website and assisting in the creation and design of interactive platforms at RA Capital and it's portfolio companies founded through the firm's incubator, RA Ventures. Jesse has more than a decade of discovery research and management experience, from early discovery through preclinical development. Lucas Guevara is a Compliance Counsel at RA Capital Management. In his role at Catamaran, he helped secure a Series A financing with a syndicate of leading investors, rapidly recruit an experienced cell therapy team, access enabling technologies, build a broad patent estate, and design external communication strategies. He is a respected biotech leader with over twenty years of biopharma experience across global organizations. Natalie Camacho is an Executive Assistant at RA Ventures (RAVen). January 3, 2023 Feb 10th, Ed. Sarah is the only lawyer to have received the NVCAs Outstanding Service Award, for her leadership role in conceiving of and spearheading the NVCA Model Legal Documents. RA Capital and CEO of Arcuate Therapeutics. Cony received a BSc in Applied Biology from the University of London and an MBA from The Open University, Milton Keynes UK. Megan Lipcsey is an Associate with the TechAtlas division of RA Capital Management. Prior to Akebia, she gained Administrative and Resource Management experience at Wellington Management and Signature Consultants, respectively. Shan Shans primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Bracketts primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Dan Marks is a Principal on the Venture Team at RA Capital Management. He holds a BA in History from University of Massachusetts, Amherst and a Master's of Urban Affairs from Boston University. Vikram trained in clinical pathology at the Brigham and Womens Hospital where he was chief resident. Anurag works on both public and private investments with a focus on Healthcare, Technology, and Services. 239 Kelton St, Allston, MA . Brian Lewandowski is an Analyst on the Investment Team at RA Capital Management. Fuads primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Prior to RA, Gunes served as a scientist within the PCMM Program at Boston Childrens Hospital and her research focused on biophysical characterization of different amyloid fibrils. Tyler holds a BA in Finance from the University of Massachusetts, Amherst and a certificate in Interactive Design from Rhode Island School of Design. BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech In addition, he designs graphics for all internal and external materials. He is the co-inventor of first-in-class HCV NS5A inhibitors, which led to the approval of DaklinzaTM, the first marketed drug in its class. After joining RA Ventures as Chief Development Officer, Ed built the development team, oversaw development of six compounds from discovery-stage through to clinical-stage, and led the formation of several new companies, including Lusaris Therapeutics. 'Peter Pan and Wendy' movie: Biggest changes from Disney animated film He worked previously as an Associate Managing Editor at EBSCO Health, and as a Medical Writer at IC Axon and Publicis Life Brands International. Prior to joining RA Capital, Jeff worked for over 10 years as an institutional equity sales trader, primarily at KCG Holdings, Inc., where he managed the Boston office. Jaimie Kirkpatrick is a Research Assistant at RA Capital Management. He completed the Executive Program at Stanford University, Graduate School of Business, as well as the Executive to Leader Institute at Korn/Ferry International. Ben Dake is a Venture Associate at RA Capital Management. Milind attended the residential Executive Program at The Wharton School of Management. Nate conducts due diligence on biotechnology companies at RA Capital and serves as a Board Director for The Covid Apollo Project and Nucleix. Ally coached Women's Lacrosse at Muhlenberg College in PA. Emilie has previously held similar roles at FLAG Capital Management and Bain Capital. She also held research roles at MIT, Children's Hospital, Harvard, and Brigham and Women's Hospital. Kritis primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Jennas primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Vanderpump Rules: How Old Is Peter Madrigal? - Screen Rant Matts primary responsibilities at RA Capital are to gather team input to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities, and to provide software training and coordinate with outside technology vendors. Camerons primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Let's Throw a Patent-Burning Party | by Peter Kolchinsky - Medium Jenna previously held roles as Senior Medical Writer and Analyst at Costello Medical Consulting. Prior to MPM, she worked as an Executive Assistant at Charles River Ventures. Adison is an Executive Assistant RA Capital Management. His laboratory at the Broad focused on advanced high throughput biotechnology tools including DNA synthesis, single cell analysis, synthetic biology derived biomolecule libraries, and microbiome profiling. Astha holds a BA in Biochemistry and Molecular Biology (with a minor in Physics) from Clark University. Roivant, he . Matthew holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA with a concentration in Finance from the University of Connecticut. Emorys primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Peter Kolchinsky on Twitter Kathryn holds a BA in Geography and Peace and Conflict Studies from Colgate University, a MSc in International Development: Environment and Development from the University of Manchester (UK), and a MA and Ph.D. in Geography from Clark University (2016).
Bluffton, Sc Flood Zones, Articles P